Circassia Pharmaceuticals (CIR): Corp Board changes – transition to the next phase of growth | Evgen Pharma (EVG): Corp Investigator-led study in NASH
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 5 December 2019
Circassia Pharmaceuticals (CIR): Corp Board changes – transition to the next phase of growth | Evgen Pharma (EVG): Corp Investigator-led study in NASH